Embla Medical hf

EMBLA · Nasdaq Copenhagen · Healthcare

26.60DKK +0.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: −15.6%

Performance

1 month

−8.3%

1 year

−15.6%

3 years, per year

−3.4%

5 years, per year

−10.3%

Largest fall, 3 years

−48.1%

Below the peak now

−52.6%

Volatility, 1 year

25.9%

Return with dividends reinvested.

Key figures

P/E

18.4

P/B

1.9

Dividend yield

0.0%

Return on equity

+10.2%

Net margin

+9.6%

Market value

1.7 bn USD

Quality, value and trend

Where Embla Medical stands against every Nordic stock today. 100 is best.

Quality93

Profitability and a sound balance sheet over time. Better than 93% of Nordic stocks.

Value58

The price measured against earnings, assets and cash flow. Better than 58% of Nordic stocks.

Trend45

The price development over the past year. Better than 45% of Nordic stocks.

Combined80

Quality, value and trend together. Better than 80% of Nordic stocks.

About Embla Medical

Embla Medical hf is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 4,500 employees.

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products, such as microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis